WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...

Please provide your email address to receive an email when new articles are posted on . Exposure to the antibiotics did not increase the risk for vancomycin-resistant Enterococcus colonization. Few ...

Antibiotic exposure and dirty hands were factors linked to nursing home contamination with the multidrug-resistant bacteria vancomycin-resistant Enterococci, or VRE, a new study finds. The report was ...

Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Stopping contact precautions for MRSA and ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE ...

WEST LAFAYETTE, Ind. — With antimicrobial resistance on the rise, many infections once easily treated are becoming fatal. Vancomycin-resistant enterococci (VRE) is to blame for more than 5% of all ...

Background: Our institution experienced an increase in the frequency of vancomycin-resistant enterococci (VRE) clinical isolates. Surveillance cultures upon hospital admission for patients at high ...

In a recent review published in the Microorganisms Journal, researchers reviewed existing data on the use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria, ...

HOUSTON -- (Aug. 12, 2019) -- To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can ...

An antibiotic substance created by bacteria found on a species of African ant native to Kenya inhibits the growth of vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus, ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...